Evaluation of effects of various drugs on platelet functions using phorbol 12-myristate 13-acetate-induced megakaryocytic human erythroid leukemia cells

References

• HuoYSchoberAForlowSBCirculating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein ENat Med200391616712483207
   PubMed Web of Science ®Google Scholar
• MassbergSBrandKGrünerSA critical role of platelet adhesion in the initiation of atherosclerotic lesion formationJ Exp Med2002196788789612370251
   PubMed Web of Science ®Google Scholar
• MassbergSVogtFDickfeldTBrandKPageSGawazMActivated platelets trigger an inflammatory response and enhance migration of aortic smooth muscle cellsThromb Res2003110418719414512080
   PubMed Web of Science ®Google Scholar
• WuKKPlatelet activation mechanisms and markers in arterial thrombosisJ Intern Med199623917348551196
   PubMed Web of Science ®Google Scholar
• BerridgeMJLippPBootmanMDThe versatility and universality of calcium signallingNat Rev Mol Cell Biol200011112111413485
   PubMed Web of Science ®Google Scholar
• JacksonSPNesbittWSKulkarniSSignaling events underlying thrombus formationJ Thromb Haemost2003171602161212871297
   PubMed Web of Science ®Google Scholar
• JangIKGoldHKZiskindAALeinbachRCFallonJTCollenDPrevention of platelet-rich arterial thrombosis by selective thrombin inhibitionCirculation19908112192252297828
   PubMed Web of Science ®Google Scholar
• WintersJKSantroSAMiletichJPEisenbergPRRelative importance of thrombin compared with plasmin-mediated platelet activation in response to plasminogen activation with streptokinaseCirculation1991844155215601833087
   PubMed Web of Science ®Google Scholar
• LaineMPaganelliFBonelloLP2Y12-ADP receptor antagonists: days of future and pastWorld J Cardiol20168532733227231519
   PubMedGoogle Scholar
• RinkTJHallamTJWhat turns platelets on?Trends Biochem Sci19849215219
   Web of Science ®Google Scholar
• JohnsonPCWareJAClivedenPBSmithMDvorakAMSalzmanEWMeasurement of ionized calcium in blood platelets with the photoprotein aequorin. Comparison with Quin 2J Biol Chem19852604206920763918996
   PubMed Web of Science ®Google Scholar
• BrassLFManningDRWilliamsAGWoolkalisMJPonczMReceptor and G protein-mediated responses to thrombin in HEL cellsJ Biol Chem199126629589651845999
   PubMed Web of Science ®Google Scholar
• TabilioARosaJPTestaUExpression of platelet membrane glycoproteins and alpha-granule proteins by a human erythroleukemia cell line (HEL)EMBO J1984324534596201359
   PubMed Web of Science ®Google Scholar
• NakajimaMYamamotoMUshikubiFOkumaMFujiwaraMNarumiyaSExpression of thromboxane A2 receptor in cultured human erythroleukemia cells and its induction by 12-O-tetradecanoylphorbol-13-acetateBiochem Biophys Res Commun198915839589652522003
   PubMed Web of Science ®Google Scholar
• LongMWHeffnerCHWilliamsJLPetersCProchownikEVRegulation of megakaryocyte phenotype in human erythroleukemia cellsJ Clin Invest1990854107210842318965
   PubMed Web of Science ®Google Scholar
• VasudevKKeownPGibbIMcAllister-WilliamsRHHematological effects of valproate in psychiatric patients: what are the risk factors?J Clin Psychopharmacol201030328228520473063
   PubMed Web of Science ®Google Scholar
• MartinPPapayannopoulouTHEL cells: a new human erythroleukemia cell line with spontaneous and induced globin expressionScience19822164551123312356177045
   PubMed Web of Science ®Google Scholar
• GrynkiewiczGPoenieMTsienRYA new generation of Ca2+ indicators with greatly improved fluorescence propertiesJ Biol Chem19852606344034503838314
   PubMed Web of Science ®Google Scholar
• LecomteMLanevilleOJiCDeWittDLSmithWLAcetylation of human prostaglandin endoperoxide synthase-2(cyclooxygenase-2) by aspirinJ Biol Chem19942691813207132158175750
   PubMed Web of Science ®Google Scholar
• GordonJMPersonJDEffects of sulphinpyrazone and aspirin on prostaglandin I2(prostacyclin) synthesis by endothelial cellsBr J Pharmacol1978644481483365283
   PubMed Web of Science ®Google Scholar
• PatronoCAspirin as an antiplatelet drugN Engl J Med1994330128712948145785
   PubMed Web of Science ®Google Scholar
• UmekawaHTanakaTKimuraYHidakaHPurification of cyclic adenosine monophosphaterase from human platelets using new-inhibitor sepharose chromatographyBiochem Pharmacol198433333933446093810
   PubMed Web of Science ®Google Scholar
• SudoTTadhibanaKTodaKPotent effects of novel anti-platelet aggregatory cilostamide analogues on recombinant cyclic nucleotide phosphodiesterase isozyme activityBiochem Pharmacol200059434735610644042
   PubMed Web of Science ®Google Scholar
• IgawaTTaniTChijiwaTPotentiation of anti-platelet aggregation activity of cilostazol with vascular endothelial cellsThromb Res1990576176232158154
   PubMed Web of Science ®Google Scholar
• MinamiNSuzukiYYamamotoMInhibition of shear stress-induced platelet aggregation by cilostazol, a specific inhibitor of cGMP-inhibited phosphodiesterase, in vitro and ex vivoLife Sci199761253833899244364
   PubMed Web of Science ®Google Scholar
• PicotDLollPJGaravitoRMThe X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1Nature199436764602432498121489
   PubMed Web of Science ®Google Scholar
• McAdamBFCatella-LawsonFMardiniIAKapoorSLawsonJAFitzGeraldGASystemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2Proc Natl Acad Sci U S A19999612722779874808
   PubMed Web of Science ®Google Scholar
• KusumiISuzukiKSasakiYKamedaKKoyamaTTreatment response in depressed patients with enhanced Ca mobilization stimulated by serotoninNeuropsychopharmacology200023669069611063924
   PubMed Web of Science ®Google Scholar
• SuzukiKKusumiIAkimotoTSasakiYKoyamaTEffects of lithium and valproate on agonist-induced platelet intracellular calcium mobilization: relevance to myosin light chain kinaseProg Neuropsychopharmacol Biol Psychiatry2004281677214687859
   PubMed Web of Science ®Google Scholar
• AkimotoTKusumiISuzukiKMasuiTKoyamaTEffects of valproate on serotonin-induced intracellular calcium mobilization in human plateletsJ Psychiatry Neurosci2007321172217245470
   PubMed Web of Science ®Google Scholar
• MacDonaldTMWeiLIs there an interaction between the cardiovascular protective effects of low-dose aspirin and ibuprofen?Basic Clin Pharmacol Toxicol200698327528016611202
   PubMed Web of Science ®Google Scholar
• OuelletMRiendeauDPercivalMDA high level of cyclooxygenase-2 inhibitor selectivity is associated with a reduced interference of platelet cyclooxygenase-1 inactivation by aspirinProc Natl Acad Sci U S A20019825145831458811717412
   PubMed Web of Science ®Google Scholar
• GidalBSpencerNMalyMValproate-mediated disturbances of hemostasis: relationship to dose and plasma concentrationNeurology1994448141814228058141
   PubMed Web of Science ®Google Scholar
• KisBSzuperaZMezeiZGecseATelegdyGVécseiLValproate treatment and platelet function: the role of arachidonate metabolitesEpilepsia199940330731010080510
   PubMed Web of Science ®Google Scholar